ArticleIndian journal of ophthalmology2026
Concurrent phakic intraocular lens explantation and phacoemulsification with IOL implantation: A retrospective analysis of efficacy and safety.
Article in Indian journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the efficacy and safety of cataract surgery in patients who underwent posterior chamber phakic intraocular lens (PCpIOL) explantation combined with phacoemulsification and intraocular lens (IOL) implantation, with a minimum follow-up period of 2 years postoperatively. Methods: Retrospective study done at a tertiary eye care hospital in South India. STUDY POPULATION: Electronic medical records of 57 eyes of patients who underwent PCpIOL explantation combined with phacoemulsification and IOL implantation due to cataract development between 2009 and 2022 were analyzed for visual outcomes, IOL power predictability, and intraoperative or postoperative complications.
interventionPhacoemulsification was performed in 54 eyes, and femtosecond laser-assisted cataract surgery (FLACS) was performed in three eyes.
main outcome measureEfficacy and safety of cataract surgery in these patients.
resultsAnterior subcapsular cataract development remains the most common cause for pIOL explantation. The phakic IOL models explanted in our study were implantable collamer lens (ICL) V4b, implantable phakic contact lens (IPCL) V1, and IPCL V2. Good improvement in corrected distance visual acuity (CDVA) was observed post-phacoemulsification, with 80.6% achieving CDVA of 0.3 logMAR or better. A total of 86.1% of the eyes were within +/-1.00 D of the target refraction (spherical equivalent). No intraoperative or early postoperative complications were noted. Posterior capsular opacification developed in 11 eyes, and retinal detachment (RD) in one eye.
conclusionPhacoemulsification post-PCpIOL explantation yields good visual outcomes, a high safety profile, and stable refraction, without increased complications. The Barrett Suite formula reliably predicts IOL power calculation. A detailed preoperative fundus examination, with emphasis on the peripheral retina, is vital prior to PCpIOL implantation and phacoemulsification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.